Ligand Pharmaceuticals reported $42.12M in Trade Debtors for its fiscal quarter ending in June of 2025.


Trade Debtors Change Date
Amgen USD 8.7B 569M Jun/2025
Arrowhead Research USD 9.7M 7.33M Jun/2025
Baxter International USD 1.65B 84M Mar/2025
Bristol-Myers Squibb USD 15.1B 515M Jun/2025
Eli Lilly USD 17.21B 3.2B Jun/2025
Gilead Sciences USD 4.78B 393M Jun/2025
GlaxoSmithKline GBP 7.7B 196M Jun/2025
Glaxosmithkline GBP 7.7B 372M Jun/2025
Insmed USD 55.03M 7.29M Jun/2025
Ionis Pharmaceuticals USD 52.58M 12.87M Jun/2025
Ligand Pharmaceuticals USD 42.12M 715K Jun/2025
MacroGenics USD 12.53M 8.22M Jun/2025
Merck USD 12.72B 1.14B Jun/2025
Pacira USD 114.37M 9.62M Jun/2025
Pfizer USD 16.09B 1.35B Jun/2025
Veracyte USD 50.81M 2.97M Jun/2025